As hair restoration science evolves, dermatologists are increasingly focusing on improving consistency and reproducibility in treatment outcomes through standardised biological signalling approaches such as Precision Re-engineered Efficacy Optimization (PREO).
One of the longstanding challenges in regenerative dermatology has been variability in biological response. For more than a decade, autologous therapies such as platelet-rich plasma (PRP) and growth factor concentrate (GFC) have been widely used in hair restoration. However, differences in individual biology and preparation techniques have often resulted in inconsistent clinical outcomes.
Experts say the shift toward PREO is being driven by a growing clinical realisation that variability, rather than efficacy, may be a key limitation in current biological approaches.
Dr. Sukesh M S, Dermato Trichologist and Hair Transplant Surgeon, Skye- Skin and Hair Sciences Clinic, Bengaluru, said, “Variability has long been recognised as a limitation in autologous biological approaches. The ability to deliver more defined and standardised signalling inputs represents an important area of exploration in regenerative dermatology. This is exactly why I am excited about what the QR678 PREO means for the science of hair loss.”
PRP vs QR678 PREO
While PRP and GFC therapies continue to hold clinical value, their dependence on patient-specific biology means that the concentration and composition of signalling molecules can vary significantly between individuals and even across treatment sessions. This inherent inconsistency has remained a topic of discussion within the dermatology community.
The PREO framework has emerged as an approach aimed at addressing this challenge. It focuses on defining, standardising, and selectively optimising pro-regenerative biological signals while minimising inhibitory influences, thereby creating a more controlled and reproducible signalling environment.
According to experts, the emerging shift in hair restoration is no longer just about stimulation, but increasingly about reproducibility.
Dr. Neha Sachde, Dermatologist, CEO and Founder, Metamorphosis Clinic, Mumbai, said, “In our clinical experience, approaches based on standardised, bioengineered signalling appear to offer greater consistency in response compared to inherently variable, patient-dependent preparations.”
Recent structured evaluations and clinical observations are also encouraging a move toward more standardised, bioengineered signalling environments designed to improve consistency and reproducibility.
The experts cited a controlled evaluation involving parallel treatment approaches, where participants received either a standardised bioengineered signalling formulation or an autologous platelet-based therapy, allowing observational comparison within a clinical setting.
Participants treated with the standardised signalling approach demonstrated measurable improvements in several clinical parameters, including global photographic assessment, terminal hair density, and reduction in hair shedding over longitudinal follow-up.
Compared with the PRP and GFC cohort, QR678 PREO demonstrated a 43.4 per cent improvement in global photographic assessment scores over the study period relative to baseline assessments.
Importantly, the observations also indicated a greater degree of consistency in treatment response across participants, addressing one of the most commonly discussed limitations of patient-dependent biological therapies.
Understanding QR678 PREO
QR678 PREO is a cosmetic formulation developed based on the principles of Precision Re-engineered Efficacy Optimization. It is designed to deliver defined, biomimetic signalling inputs in a standardised manner, to support follicular function and improve consistency of biological response.
Experts believe the growing emphasis on standardised biological signalling reflects a broader shift in regenerative dermatology — shifting from variability toward precision, and from empirical procedures toward more defined and reproducible biological environments.
“The focus is gradually shifting from simply stimulating biological activity to creating more structured and reproducible signalling environments, and QR678 PREO reflects this broader movement toward structured signalling environments,” said Dr. Md Imran Ali, Expert Dermatologist and Hair Transplant Surgeon at Dermax Skin & Hair Transplant Clinic, Hyderabad.
As interest in precision-based regenerative therapies continues to grow, frameworks such as PREO are contributing to a more structured understanding of how biological signals can be organised and delivered in clinical practice.
QR678 PREO represents one such cosmetic application emerging within this evolving paradigm of precision-driven and reproducible approaches to hair restoration.
